Retail Clinics

  • Zicam introduces Cold Remedy Plus line

    PHOENIX Matrixx Initiatives recently introduced a new line of Zicam products — Cold Remedy Plus, a multi-ingredient formulation that both reduces the duration of the common cold and helps relieve the symptoms of someone who already has a cold.

    The Cold Remedy Plus products, cherry-flavored Liqui-Loz and cherry-flavored Zavors, retail for a suggested $11.59. Two mint flavors — including a rapid melt and oral mist — will launch in the fall.

  • AccuDial to roll out dosing system

    PALM BEACH GARDENS, Fla. AccuDial Pharmaceutical recently shared plans to launch its line of patented dosing systems in the United States this fall. The system features an accurate dosing spoon, coupled with weight-based dosing recommendations, as opposed to age-based dosing recommendations found on many kids' product labels today.

     

  • New no-touch thermometer to hit store shelves this summer

    BUFFALO, N.Y. American Scientific Resources plans to launch a premium thermometer — the Kidz+Med NeverTouch 5-in-1 — beginning Aug. 1.

     

    The no-touch thermometer allows mom to take her child’s temperature without waking them if their asleep. Other uses include determining the temperature of a feeding bottle, bath water or even an ambient temperature. The company is planning a $1.5 million consumer ad spend this fall, reaching consumers on all three major networks as well as Bravo and the Weather Channel.

     

     

  • Study: Combined lipid, blood pressure therapies don’t reduce diabetes patients’ cardiovascular risk

    NEW YORK Diabetes patients combining drugs to control blood fat and blood pressure may remain at risk for heart attacks and other heart disease, according to a study presented in Atlanta on Sunday.

  • Merix unveils new over-the-counter genital herpes treatment

    BARRINGTON, Ill. Merix Pharmaceutical unveiled its new Fast-Results! genital herpes treatment this month while attending the ECRM Cough, Cold and Allergy conference in Dallas.

    The only OTC treatment for genital herpes, Fast-Results! answers an unmet need of people who suffer painful symptoms associated with genital herpes outbreaks. Designed to be used in conjunction with prescription medication, Fast-Results! also brings needed treatment to consumers who cannot afford prescription medication.

  • CVS Caremark survey: Cost management a top priority for employers

    WOONSOCKET, R.I. Most employers consider managing costs a top priority in 2010, according to CVS Caremark’s annual employer survey.

  • Waterpik expands product offerings with SinuSense

    FORT COLLINS, Colo. Perhaps best known for its dental water jet systems, Waterpik recently made a foray into nasal irrigation solutions with a family of products under the Waterpik SinuSense banner. Sinus washing is a natural daily routine to keep sinus passages clear of congestion, allergens and everyday debris, reducing the risk of cold and allergy symptoms.

     

  • Take Care Clinics adds camp, sports physicals to offerings

    CONSHOHOCKEN, Pa. Take Care Health Systems, which is owned by Walgreens, has announced that it now is offering camp and sports physicals at all Take Care Clinics nationwide.

    The clinics, located within nearly 360 Walgreens stores nationwide, are offering physicals for $35 through the end of September. The physicals are administered by nurse practitioners and, in select markets, physician assistants.

     

  • Study finds most nurse practitioners recommend dietary supplements to patients

    WASHINGTON The vast majority of nurse practitioners are actively recommending dietary supplements to their patients, the CRN Foundation, an educational affiliate of the Council for Responsible Nutrition, announced Wednesday.

  • Study underscores importance of physician-pharmacist collaboration

    MONTREAL Care offered to patients improved when physicians collaborated with community pharmacists, according to a Canadian study published Monday in the Canadian Medical Association Journal.

     

    Researchers at the Universite de Montreal and McGill University focused on patients with high cholesterol at risk for developing cardiovascular disease, recruiting 77 physicians, 108 pharmacists and 225 patients.

     

     

X
This ad will auto-close in 10 seconds